Amazon sells GLP‑1 access

Amazon is turning weight-loss drugs into a standard pharmacy offering, saying patients can now get Wegovy and newer glucagon-like peptide-1 pills through Amazon Pharmacy. (cnbc.com) The company said insured customers will pay as little as $25 a month, and it framed the program around fast delivery, clear pricing and refill support through Amazon Pharmacy. Amazon already lists Wegovy on its pharmacy site and routes some patients through One Medical for evaluation and prescribing. (cnbc.com) (pharmacy.amazon.com) (health.amazon.com) GLP-1 drugs copy a gut hormone that helps people feel full and lowers blood sugar, which is why they became big sellers for obesity and diabetes. Amazon said the new program covers Novo Nordisk’s Wegovy and oral GLP-1 options, expanding beyond the injectable drugs that drove the first wave of demand. (health.amazon.com) (cnbc.com) The timing follows a rapid shift in the market from scarcity to broader distribution. Amazon began offering Novo Nordisk’s Wegovy pill in January 2026, and Novo Nordisk said this month that Wegovy HD, a higher-dose injection, is now available nationwide. (cnbc.com) (novonordisk-us.com) Federal regulators have also widened the field for oral treatments. The Food and Drug Administration approved Wegovy tablets in April 2026 and approved Eli Lilly’s oral obesity drug, Foundayo, earlier the same month. (accessdata.fda.gov) (fda.gov) (accessdata.fda.gov) That gives Amazon a larger menu to sell just as drugmakers and pharmacies push patients toward branded, Food and Drug Administration-approved products. The Food and Drug Administration has warned consumers about unapproved and compounded GLP-1 products used for weight loss, while Amazon says some branded GLP-1 drugs still face marketplace constraints and it is prioritizing certain existing customers. (fda.gov) (amazon.com) Novo Nordisk has been building its own direct access channels at the same time. On March 31, 2026, the company launched a multi-month subscription program for Food and Drug Administration-approved Wegovy that it said could save patients up to $1,200 a year. (novonordisk-us.com) Amazon’s move does not change who can get these medicines: a clinician still has to decide whether a patient qualifies and write the prescription. It does change where patients can shop for them, with a retail giant now bundling telehealth, pharmacy fulfillment and home delivery around one of the hottest drug categories in the U.S. (health.amazon.com) (cnbc.com)